Search - tctmd.com

Displaying 401 - 420 of 1551

Sort: Relevancy | Date

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

L.A. McKeown

February 11, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Daily News

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Todd Neale

February 10, 2020

News Daily News

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Michael O'Riordan

January 17, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Todd Neale

January 15, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Daily News

Diabetes Does Not Appear to Hinder FFR Insights for CAD

Caitlin E. Cox

January 09, 2020

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

News Conference News AHA 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Yael L. Maxwell

November 21, 2019

News Conference News AHA 2019

EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl

Todd Neale

November 18, 2019

News Conference News AHA 2019

No Benefit of Colchicine in All-Comers PCI

Shelley Wood

November 17, 2019

News Conference News AHA 2019

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Yael L. Maxwell

November 17, 2019

News Daily News

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

Michael O'Riordan

November 11, 2019

News Daily News

Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most

Yael L. Maxwell

November 07, 2019

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

Presentation Cardiovascular Interventions 2019

PCSK9 Inhibitors for the Interventionalist: Which Patients Do We Choose and How Do We Use?

Presenter: Matthew J. Budoff

November 01, 2019

News Daily News

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

L.A. McKeown

November 01, 2019

News Daily News

Sex-Based Nuances Seen in iFR and FFR Testing: DEFINE-FLAIR

Caitlin E. Cox

October 24, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

Advertisement

Outcome Differences Between Men and Women With PAD: EUCLID Insights

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Diabetes Does Not Appear to Hinder FFR Insights for CAD

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl

No Benefit of Colchicine in All-Comers PCI

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

PCSK9 Inhibitors for the Interventionalist: Which Patients Do We Choose and How Do We Use?

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

Sex-Based Nuances Seen in iFR and FFR Testing: DEFINE-FLAIR

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content